Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

RENX vs AIMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AIMD Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 8–2 Matrix Metrics)

AIMD Overall Winner 6-Pillar Tally: RENX 1 – 3 AIMD (2 Tie) Matrix Metrics: RENX 2 – 8 AIMD

As of Nov 20, 2026, Ainos, Inc. (AIMD) is the stronger overall head-to-head candidate over RENX (RENX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RENX carries a Unified Composite Score of 44.0/100 (HOLD) at $0.74 (N/M Forward P/E, N/A operating margin), whereas AIMD carries 23.4/100 (STRONG SELL) at $1.18 (13.9x Forward P/E, -101210.2% operating margin).

  • Composite vs. Pillar Nuance: While RENX currently prints a higher short-term Unified Composite Score (44.0/100 HOLD vs. AIMD 23.4/100 STRONG SELL), AIMD captures the overall institutional head-to-head verdict (8–2 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-101210.2% vs. N/A operating margin) and revenue trajectory (-96.7% vs. N/A YoY).
  • Technical & Structure Timing Caution: RENX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.6); meanwhile AIMD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 59.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RENX vs AIMD
RENX US Equity
RENX
Institutional Equity
$0.74
-23.09% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -17.85β · 161% Vol
Unified Composite Score
44.0 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.4%), weak momentum, RSI 32
RSI-14: 31.6 · SMA20: $1.05 · SMA50: $1.49
AIMD NASDAQ Head-to-Head Winner
Ainos, Inc. Common Stock
Pharmaceutical Preparations
$1.18
+6.31% 1D
Market Cap $8.4M
TTM Revenue $13,600
Forward P/E 13.9x
Beta / 30D Vol 2.03β · 437% Vol
Unified Composite Score
23.4 / 100 STRONG SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 59
RSI-14: 59.3 · SMA20: $0.84 · SMA50: $1.06

6-Pillar Scorecard Institutional Category Breakdown (RENX 1 – 3 AIMD)

Columns: Metric · RENX · AIMD
1. Valuation Multiples AIMD
Forward P/E N/M 13.9x
Trailing P/E N/M 13.9x
PEG Ratio N/M 0.93x
EV / Revenue N/M N/M
2. Growth & Scale AIMD
Revenue Growth (YoY) N/A -96.7%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $13,600
Market Cap N/A $8.4M
3. Profitability & Quality AIMD
Gross Margin N/A 78.7%
Operating Margin N/A -101210.2%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -196.3%
4. Balance Sheet & Cash Flow RENX
Cash Generation (TTM) N/A -$4.4M
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $11M Net Debt (2.43x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RENX (2) vs AIMD (8)
Institutional Metric RENX AIMD Criterion Row Edge
Market Capitalization
Scale
N/A $8.4M Larger Scale AIMD
Trailing P/E Ratio
Valuation
N/M 13.9x Lower Multiple AIMD
Forward P/E Ratio
Valuation
N/M 13.9x Lower Multiple AIMD
Revenue Growth (YoY)
Growth
N/A -96.7% Higher Growth AIMD
Operating Margin (TTM)
Profitability
N/A -101210.2% Higher Margin AIMD
Net Profit Margin
Profitability
N/A 0.0% Higher Margin AIMD
Return on Equity (ROE)
Capital Efficiency
N/A -196.3% Higher ROE AIMD
52-Week Range Position
Momentum
19% ($0–$3) 22% ($0–$4) Stronger Trend AIMD
Beta / 30D Volatility
Risk Regime
-17.85β · 161% Vol 2.03β · 437% Vol Lower Realized Risk RENX
Unified Institutional Score
Composite Signal
44.0 / 100 (HOLD) 23.4 / 100 (STRONG SELL) Higher Composite RENX
Trailing 12M Revenue (USD)
Operating Scale
N/A $13,600 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 78.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.93x PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$4.4M ($11M Net Debt (2.43x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AIMD +88.0 pp
RENX: -48.21% · AIMD: +39.79%
3M Horizon AIMD +47.56 pp
RENX: -62.67% · AIMD: -15.11%
6M Horizon AIMD +29.67 pp
RENX: -52.55% · AIMD: -22.88%
1Y Horizon RENX +207.66 pp
RENX: +163.58% · AIMD: -44.08%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RENX vs AIMD. Trailing 12-month operating profitability (RENX N/A vs AIMD -101210.2%) and valuation multiples (RENX N/M vs AIMD 13.9x Forward P/E) are benchmarked directly in Pillar 4 below.

RENX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
AIMD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$13,600
Gross Margin78.7%
Op. Margin-101210.2%
ROE / Fwd P/E-196.3% · 13.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RENX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RENX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AIMD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AIMD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RENX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AIMD Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.4M market capitalization and -101210.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ RENX vs AIMD Key Questions & Quantitative Answers

As of Nov 20, 2026, Ainos, Inc. (AIMD) is the stronger overall head-to-head candidate over RENX (RENX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RENX carries a Unified Composite Score of 44.0/100 (HOLD) at $0.74 (N/M Forward P/E, N/A operating margin), whereas AIMD carries 23.4/100 (STRONG SELL) at $1.18 (13.9x Forward P/E, -101210.2% operating margin). Composite vs. Pillar Nuance: While RENX currently prints a higher short-term Unified Composite Score (44.0/100 HOLD vs. AIMD 23.4/100 STRONG SELL), AIMD captures the overall institutional head-to-head verdict (8–2 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-101210.2% vs. N/A operating margin) and revenue trajectory (-96.7% vs. N/A YoY). Technical & Structure Timing Caution: RENX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.6); meanwhile AIMD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 59.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AIMD leads the Growth & Scale pillar: RENX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with AIMD at -96.7% YoY revenue growth and +0.0% YoY earnings growth on $13,600 TTM revenue (78.7% gross margin, -101210.2% operating margin). On trailing 12-month operating scale, RENX generates N/A in USD-normalized revenue versus $13,600 for AIMD. In operating R&D and SG&A reinvestment, RENX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AIMD.

AIMD screens cheaper on headline valuation multiples. RENX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AIMD trades at 13.9x Forward P/E, 13.9x Trailing P/E, 0.93x PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RENX (N/A ROE) versus AIMD (-196.3% ROE) capital efficiency.

In options market volatility and institutional positioning, RENX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-17.85β · 161% Vol realized risk). By comparison, AIMD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.03β · 437% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.